Status
Conditions
Treatments
About
The aim of this study is to examine the effects of virtual reality glasses applied to individuals who will undergo pleural catheter placement on pain, anxiety, and vital parameters. The main research questions that the study aims to answer are as follows:
The researcher compared the intervention and control groups to determine whether the glasses have an effect on the measurable parameters (pain, anxiety, and vital signs).
Full description
Today, both pharmacological and non-pharmacological methods are used to reduce patients' pain and anxiety during invasive procedures. Distraction techniques hold an important place among non-pharmacological methods. Virtual reality (VR) glasses can be effective in reducing perceived pain and anxiety by allowing patients to divert their attention elsewhere during procedures.
This study was conducted to evaluate the distribution of virtual reality brightness on patients' pain and anxiety levels.
The study was designed as a randomized controlled trial by the researchers. The patients included in the study were divided into two groups: the intervention group (exposed to virtual reality) and the control group (standard care). Following stratified randomization, randomization was carried out using a simple random number table.
Application:
During the insertion phase, Shinecon brand virtual reality glasses were placed on the patients during the connection process, and underwater images were shown.
During routine phases, no distraction method was applied, and only the procedure was followed.
All patients' vital signs (blood pressure, heart rate, oxygen saturation) were recorded before, during, and after the procedure. Pain levels were assessed using the Visual Analog Scale (VAS) before and after the procedure. Additionally, anxiety levels were measured using the State-Trait Anxiety Inventory (STAI-S, STAI-T) before and after the procedure.
This study supports the use of virtual reality technology as a non-pharmacological intervention to improve patient comfort during minimally invasive procedures and provides evidence-based information.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Written or verbal consent to participate, Being over 18 years of age, Not having any psychiatric diagnosis, Not having any problems with vision, hearing, perception or communication.
Exclusion criteria
Being unconscious Experiencing pain due to any other problem
Primary purpose
Allocation
Interventional model
Masking
78 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal